John M. Climaco

John M. Climaco, listed as chief executive, has filed trades across 6 companies (mainly through SEC (Form 4)), most often in Digirad Corp, Perma FIX Environmental Services Inc and CNS Pharmaceuticals, Inc. Over a trading history stretching from 26 August 2013 to 1 February 2024, the count stands at 28 filings.

Purchases make up the whole of the open-market record (8 purchases, €102k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 14 share grants and 5 option exercises. So far in 2024, the count stands at 1 purchase and no sales.

A typical purchase (the median) is worth €8,454. On 2 out of 4 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 6 February 2024, the filings show an open-market purchase worth €46k in CNS Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.